Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB12878InvestigationalSmall molecule
AV-101 has been used in trials studying the treatment of Neuropathic Pain.
- Mechanism
- Curator reviewed
Pharmacologically active on NMDA receptor
- Formula / weight
- C10H11ClN2O3 · 242.66 g/mol (avg)
- Also known as
- 4-chlorokynurenine
- Code names
- AV-101 · J578.071C
Resolves to
Structure
InChIKey
HQLHZNDJQSRKDT-QMMMGPOBSA-NSMILESN[C@@H](CC(=O)C1=C(N)C=C(Cl)C=C1)C(O)=OWhat you can answer from here — as of July 07, 2026
Which companies are running trials of AV-101, in which indications and phases, and which of those programs are still active?